Get the Stockscreener App
3.27
2.10%
-0.07
Pre-market:
3.27
Fortress Biotech Inc stock is traded at $3.27, with a volume of 413.07K.
It is down -2.10% in the last 24 hours and up +18.48% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
See More
Previous Close:
$3.34
Open:
$3.36
24h Volume:
413.07K
Relative Volume:
0.87
Market Cap:
$108.63M
Revenue:
$66.16M
Net Income/Loss:
$128.94M
P/E Ratio:
1.0276
EPS:
3.1823
Net Cash Flow:
$152.08M
1W Performance:
-1.80%
1M Performance:
+18.48%
6M Performance:
-5.49%
1Y Performance:
+65.99%
1-Day Range:
$3.225
$3.505
1-Week Range:
$3.225
$3.65
52-Week Range:
$1.77
$4.53
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
3.27 | 108.63M | 66.16M | 128.94M | 152.08M | 3.1823 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 37.17B | 4.29B | 577.22M | 641.34M | 4.2086 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Fortress Biotech Inc (FBIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fortress Biotech Inc (FBIO) Balance Sheet - TradingKey
Fortress Biotech Inc (FBIO) Institutional Confidence - TradingKey
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing - The Manila Times
FBIO|Fortress Biotech Inc|Price:3.340|Chg%:-0.090 - TradingKey
Fortress Biotech Inc (FBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fortress Biotech Inc (FBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - TradingView
Fortress Biotech Inc (FBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fortress Biotech Inc (FBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy - Seeking Alpha
Fortress Biotech Preferred Stock (FBIOP) Holds Steady Near Support Amid Low Volume TradingMerger Arbitrage - dars.gov.et
Technical Reactions to FBIOP Trends in Macro Strategies - Stock Traders Daily
$3.74 | Fortress Biotech, Inc. Common Stock (FBIO) Stock Price Today - Binance
Fortress Biotech Achieves 73.6% Return in the Stock Market Over Past Year - MarketsMojo
MSN Money - MSN
CNB0 Bond Coupon Profile — Rate & Payments - TradingView
Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 Billion - BioBuzz
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock DeclinesEarnings Weakness Phase - dars.gov.et
Fortress Biotech (FBIO) Edges Lower Amid Quiet Trading, Holds Above Key SupportWeekly Profile - DonanımHaber
Fortress Biotech highlights its biotech portfolio strategy as a Nasdaq-listed micro-cap - Ad Hoc News
Mustang Bio (MBIO) Registration Filing Summary - Quartr
Fortress Biotech Preferred Shares (FBIOP) Slide 1.98% as Support Test ApproachesPut Flow Alert - dars.gov.et
Fortress Biotech focuses on specialty pharma growth and licensing model - Ad Hoc News
Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 B - GuruFocus
Fortress Biotech (FBIO) Slides 2.14% as Selling Pressure Persists Near Support LevelHigh Dividend Factor - dars.gov.et
Fortress Biotech Inc highlights its specialty pharma model as investors assess long-term prospects - Ad-hoc-news.de
Fortress Biotech, Inc. Actuals & Estimates (NASDAQ:FBIO) - TradingView
Trading the Move, Not the Narrative: (FBIOP) Edition - Stock Traders Daily
FBIO Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView
Form 4 Fortress Biotech Inc For: 24 June By Investing.com - Investing.com Nigeria
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance
Fortress Biotech (NASDAQ: FBIO) CFO receives 400,000 RSU award - Stock Titan
Enterprise value to revenue forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView
FBIOP Q1 2026 Earnings: Significant EPS Miss Highlights Ongoing Challenges for Fortress BiotechAnalyst Coverage Count - dars.gov.et
Fortress Biotech (NASDAQ: FBIO) reports 2026 director and auditor vote tallies - Stock Titan
Fortress Biotech Inc (FBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fortress Biotech Inc. (FBIO) Q4 2025 Earnings: EPS Misses Estimates on Higher R&D CostsCash Flow Report - dars.gov.et
Fortress Biotech StockSaturday deep dive on the business model - AD HOC NEWS
Fortress Biotech Inc (FBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mustang Bio Inc (MBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fortress Biotech (FBIO) AGM 2026 Summary - Quartr
Fortress Biotech Inc Annual Shareholders Meeting Transcript - GuruFocus
Fortress Biotech Inc (FBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fortress Biotech Inc. Q4 2025 Earnings: EPS Misses Estimates, Stock Rises Amid Strategic UpdateRevenue Miss Report - dars.gov.et
(FBIOP) Volatility Zones as Tactical Triggers - Stock Traders Daily
FBIOP Q4 2025 Earnings: Preferred Stock Reports Wider-than-Expected Loss Amid Narrowing Pipeline Progress - newsline.com
Fortress Biotech Preferred Stock (FBIOP) Edges Higher Before Resistance TestPut Support - newsline.com
Why Is Fortress Biotech Stock Falling Today? - MSN
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):